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Background: Diffuse noxious inhibitory controls (DNIC) can be produced by different types of conditioning stimuli,
but the analgesic properties and underlying mechanisms remain unclear. The aim of this study was to differentiate
the induction of DNIC analgesia between noxious electrical and inflammatory conditioning stimuli.
Methods: First, rats subjected to either a supramaximal electrical stimulation or an injection of high-dose formalin
in the hind limb were identified to have pain responses with behavioral evidence and spinal Fos-immunoreactive
profiles. Second, suppression of tail-flick latencies by the two noxious stimuli was assessed to confirm the presence
of DNIC. Third, an opioid receptor antagonist (naloxone) and an a2-adrenoreceptor antagonist (yohimbine) were
injected, intraperitoneally and intrathecally respectively, before conditioning noxious stimuli to test the involvement
of descending inhibitory pathways in DNIC-mediated analgesia.
Results: An intramuscular injection of 100 μl of 5% formalin produced noxious behaviors with cumulative pain
scores similar to those of 50 μl of 2% formalin in the paw. Both electrical and chemical stimulation significantly
increased Fos expression in the superficial dorsal horns, but possessed characteristic distribution patterns
individually. Both conditioning stimuli prolonged the tail-flick latencies indicating a DNIC response. However, the
electrical stimulation-induced DNIC was reversed by yohimbine, but not by naloxone; whereas noxious formalin-
induced analgesia was both naloxone- and yohimbine-reversible.
Conclusions: It is demonstrated that DNIC produced by different types of conditioning stimuli can be mediated
by different descending inhibitory controls, indicating the organization within the central nervous circuit is
complex and possibly exhibits particular clinical manifestations.
Background
Nociception is dynamically regulated by endogenous
modulation systems, and final pain perception depends
on a balance between nociceptive stimulation and the
processing networks. Diffuse noxious inhibitory controls
(DNIC), among the networks, occur when a painful sti-
mulus (i.e., a conditioning stimulus) in one body region
suppresses another noxious response (i.e., a test stimu-
l u s )i nar e m o t eb o d yr e g i o n[ 1 , 2 ] ,a n di sa ni m p o r t a n t
mechanism to modulate the activations of nociceptive
convergent neurons (wide-dynamic-range neurons) at
spinal cord or trigeminal nucleus through an inhibitory
pathway descending from the lower brainstem [1-4].
Nevertheless, interactions between conditioning stimuli
and analgesic responses are largely in unclarity.
DNIC can be triggered by different types of condition-
ing stimuli, e.g., noxious heat, cold water [5-7], cold
presser [8], a brief electrical stimulus [9], and a CO2
laser [10]. However, DNIC effects differ depending on
the types of conditioning stimuli, and also on the qual-
ity, magnitude, and activated nerve fibers [1,2]. For
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vate Aδ and C fibers or to induce pain showed heteroto-
pic analgesia in animals [11-14] and humans [15,16]. In
contrast, electroacupuncture (EA), another form of elec-
trical stimulation using a much-lower intensity, also
produce remote analgesic effects. It was therefore intri-
guing to investigate whether analgesic quality is differen-
tial between high-intensity (noxious) electrical
stimulation and low-intensity EA-like stimulation.
Inflammation also results in pain; however, inflamma-
tory pain-induced DNIC have seldom been studied. A
formalin injection in the rat paw results in local inflam-
mation and pain. It was reported that pinch-induced pain
at the hindpaw was inhibited by formalin injection in the
forepaw by evidence of decrease in Fos expression [17], a
pain marker [18-20], suggesting a DNIC effect. However,
the presence of DNIC in an inflammatory conditioning
may be complicated because studies from monoarthritic
animals [21] and rheumatoid arthritic humans [22] indi-
cated that the arthritic duration (acute vs. chronic), pain
pattern (evoked vs. constant), and applied pain type
(mechanical or thermal) all caused different results in the
second pain (test stimulation). Accordingly, the purpose
of this study was to investigate underlying differences in
DNIC responses to two conditioning stimuli, a supra-
maximal electrical stimulation and an injection of high-
dose formalin, applied to the same area. Three sequential
steps were undertaken to achieve this aim. First, identify
nociceptive qualities of the two conditioning stimuli by
behavioral observations and neural activations; second,
compare heterotrophic analgesic effects (DNIC) between
the two conditioning stimuli by the tail-flick test; and
third, with a pharmacological approach, differentiate the
recruited descending pathways involved in DNIC
responses to the conditioning stimuli.
Methods
1. Animal preparation and inhalational anesthetic
technique
Male Sprague Dawley rats (250-350 g, BioLASCO Tai-
wan, Taipei, Taiwan) were housed in groups of two or
three at 23 ± 1°C with a 12-h dark-light cycle with food
and water available ad libitum. Studies were performed
under approval of the Animal Care and Use Committee
of Shin-Kong Wu Ho-Su Memorial Hospital, and strictly
followed Guidelines for the Care and Use of Experimen-
tal Animals [23].
All experiments, except that in Methods section 2.2,
were conducted under an previously reported anesthetic
model [24]. In brief, rats were rapidly anesthetized in an
acryl chamber containing halothane-soaked cotton, and
then transferred to a transparent tube connected to a
breathing circuit pre-filled with 0.75% halothane in pure
oxygen with a flow of 2 L/min. The halothane
concentration was monitored with a gas analyzer. A 10-
to 15-min “induction period” was necessary to keep ani-
mals at a stable anesthetic level [24]. As long as stable
tail-flick latencies (TFLs) were obtained, conditioning
stimuli were begun, and anesthesia was maintained to
the end of the study. Usually, animals recovered to a
conscious, freely movable condition in 5 min after
anesthesia removal.
2. Noxious conditioning stimulation
2.1 The supramaximal electrical stimulation
The electrical stimulation was modified from our pre-
vious study [24]. One pair of stainless steel needles
(30G) was inserted to a depth of 5 mm in the right acu-
point Zusanli (ST36), a point located 5 mm inferolateral
to the right fibular tuberosity and in the upper one-
third of the anterior tibial muscle, and a reference point
10 mm below. Electricity was generated by a Grass S88
stimulator (Astro-med, Grass, Warwick, RI, USA) with
two Grass constant current units to deliver the electric
current of square pulses at 4 Hz with a 0.5-ms pulse
width. The stimulating current was increased from a
level producing local muscle twitching at about 0.3-0.4
mA (twitch intensity, or abbreviated as TI) to the target
intensities within 5 min. Three target intensities were
10×TI (3-4 mA; and named as E10), 20×TI (6-8 mA;
E20) and a supramaximal intensity (E50), which was as
high as the animals could tolerate (usually 50-80×TI or
> 20 mA). Total stimulating period was 30 min. Charac-
teristic rhythmic dorsiflexion of the stimulated hind
limb was always seen.
2.2 Intramuscular (i.m.) formalin injection and weighted
pain scores
To determine which concentration of i.m. formalin
would cause a hyperalgesic effect analog to that of an
intraplantar (i.pl.) injection, weighted pain scores were
used to measure the responsiveness of graded concen-
trations from 5% to 20%. First, we tested the appropriate
concentration, volume, and depth of formalin required
to induce nociceptive behaviors. In conscious rats, 100
μl of 5%, 10%, or 20% formalin, or normal saline (abbre-
viated as Fm5, Fm10, Fm20, and NS, respectively) was
injected into the right Zusanli point. An injection with
50 μl of 2% formalin (Fp) in the plantar surface of the
right hindpaw served as a positive control group. After
injection, the rats were transferred to an open iron-wire
cage for an 1-h evaluation using a modified weighted
pain score method [25]. The scores of an early phase
(0-15 min), late phase (20-60 min), and total phase
(0-60) were separately calculated for comparison.
To confirm the spread of the injection, 20 μl of methy-
lene blue was added to the formalin solution in some
rats, and the extent by which the injectate spread in mus-
cles was examined after the animals were sacrificed.
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immunohistochemistry
To investigate neuronal activation by the conditioning sti-
muli, Fos-immunoreactive (Fos-ir) profiles in the lumbar
dorsal horns were analyzed. Rats from the Fm20, E20, and
E50 groups were sacrificed at 90 min after the beginning
of the conditioning stimulation. Rats were intraperitone-
ally injected with an overdose of 650 mg/kg chloral
hydrate (Kanto Chemical, Tokyo, Japan) and transcardially
perfused with 250 ml of saline followed by 350 ml of 4%
paraformaldehyde in 0.1 M phosphate-buffered saline
(PBS, pH 7.4, 4°C). The L2-L5 spinal segments were
removed, post-fixed in the same paraformaldehyde solu-
tion at 4°C for 6 h, and cryoprotected in 30% sucrose at 4°
C for 48-72 h. Frozen sections were cut in a cryostat (30
μm) and collected in PBS as free-floating sections. They
were then incubated with primary rabbit polyclonal anti-
Fos antiserum (1: 1500, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), and diluted in 0.1 M PBS containing 3%
normal goat serum and 0.3% Triton X-100 at 4°C for 24 h.
After washing in PBS, sections were incubated with a bio-
tinylated goat anti-rabbit secondary antibody (1: 200, Vec-
tor Laboratories, Burlingame, CA, USA) in PBS for 1 h at
room temperature, and subsequently reacted with the avi-
din-biotin-peroxidase complex (Elite ABC kit, Vectastain®,
Vector Laboratories) for 1 h at room temperature. After
rinsing in 0.1 M PBS for 20 min, sections were reacted
with a 3,3’-diaminobenzidine tetrahydrochloride solution
in PBS containing hydrogen peroxide and nickel (Peroxi-
dase substrate kit, Vector Laboratories) for 6 min. All sec-
tions were mounted on gelatin-dubbed slides, air dried,
and protected with a coverslip for inspection under a light
microscope.
Sections were examined under a Nikon E600 micro-
scope (Tokyo, Japan) using a dark field to determine the
segmental levels [26] and a light field for cell counting.
The spinal dorsal horn was divided into three regions:
(1) the superficial layer (laminae I/II); (2) the nucleus
proprius (laminae III/IV); and (3) the deep layer (lamina
V). Immunoreactive neurons, which had deep staining
distinguishable nuclei from the background, were
counted by laminae. For each animal, at least 8-10 sec-
tions of each segment were examined, counted, and
averaged by segment. Antibody specificity and immu-
nostaining were tested by omission of the primary anti-
bodies. The evaluator who did the counting was blind to
the group allocation of the samples.
3. DNIC effect
3.1. Tail flick test as a test stimulus to evaluate analgesic
effect
The DNIC effects were analyzed by tail flick test. With
strict control of the ambient temperature at 23°C, the
rat tail was heated at the distal one-third by radiant
light from a focused projection bulb in an algesic device
( M K - 3 3 0 B ,M u r o m a c h iK i k a iC o .L t d . ,T o k y o ,J a p a n ) .
The baseline “tail flick latency” (TFL) was 8-10 s in
naive rats, and the tail was passively removed at 20 s, as
the “cutoff limit”.T h e“basal latency” was measured
after the anesthetic induction period and before the con-
ditioning stimulus, or the time point 0. The “test
latency” at each time point was an average of two suc-
cessive tests, separated by 2 min, without pause of elec-
trical stimulation. The maximal possible effect (MPE)
was calculated as: MPE% = [(test latency - basal
latency)/(20 - basal latency)] × 100%.
3.2. DNIC effects produced by two conditioning stimuli
Five groups were included: (1) a control group (C) in
which rats were inserted with needles but received no
electrical stimulation; (2) an E10 group in which rats
were given electrical stimulation at 10×TI; (3) an E20
group in which rats were given electrical stimulation at
20×TI; (4) an E50 group in which rats were given supra-
maximal electrical stimulation at 50-80×TI, or as high as
the rats could tolerate; and (5) a Fm20 group in which
rats were given an i.m. injection of 100 μl of 20% forma-
lin in the right ST36 acupoint. All experiments were
conducted under the same conditions of equal anes-
thetic levels and periods, basal latencies, and TLF time
points (Fig. 1). In particular, our anesthetic device
allowed three rats to be simultaneously anesthetized, so
three groups (electrical, formalin, and control) could be
matched under identical conditions and environmental
biases would be greatly decreased. Each group contained
at least nine rats. Rats were sacrificed at the end of the
study for immunostaining.
4. The mechanistic study of DNIC-mediated analgesia
To differentiate mechanisms underlying DNIC between
the electrical and formalin stimulations, involvement of
inhibitory pathways were examined by neurotransmitter
antagonists. Two agents were used: naloxone (Genovate
Biotech, Hsinchu, Taiwan), an opioid receptor antago-
nist, and yohimbine (Sigma-Aldrich, St. Louis,
MO, USA), a selective a2-adrenoreceptor antagonist.
Naloxone was intraperitoneally injected twice, 2 mg/kg
at time point -15 and 1 mg/kg at time point 30.
Yohimbine was intrathecally (i.t.) injected with a dose of
30 μgi n2 0μl of saline at the time point -15. The i.t.
injection is a single bolus technique at the L5-L6 inter-
space using a 26-gauge needle and microsyringe
(Hamilton, Reno, NV, USA) described elsewhere [27].
Both conditioning stimulations were tested with one of
the antagonists and were compared with data of
the control groups injected with an equal volume of sal-
ine vehicle. At least seven rats were included in each
group.
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All quantitative data are expressed as the mean ± stan-
dard error of the mean (SEM). Cumulative values of
weighted pain scores at 0-15, 20-60, and 0-60 min, as
well as cumulative TFLs over 0-90 min were transfor-
mations of the area under curve (AUC). The averaged
TFL at each time point, AUCs, and Fos-ir cells were
compared with one-way analysis of variance (ANOVA)
followed by post hoc Bonferroni’s test or Student’s t-test.
Av a l u eo fp < 0.05 was considered statistically
significant.
Results
1. Supramaximal electrical stimulation and i.m. formalin
injection induced noxious behaviors
1.1. Supramaximal electrical stimulation was noxious
It is apparent that noxious behaviors were shown in the
halothane-anesthetized rats subjected to the supramaximal
Figure 1 Weighted pain score [24,25]of a formalin injection in the hind limb. (A) An i.m. injection of 100 μlo f5 %( F m 5 ) ,1 0 %( F m 1 0 ) ,o r
20% (Fm20) formalin in the anterior tibial muscle induced dose-dependent pain scores and a biphasic pain pattern similar to that of a
subcutaneous plantar injection (2%, 50 μl, Fp). The Fm20 group had a lower pain score in the early phase and fewer flinch responses for the
entire period compared to the Fp group. However, the Fp and Fm20 groups had similar highest pain scores in the late phase. (B) The Fm20
group showed no statistical difference in the cumulative pain score from that of the Fp group, indicating the muscular injection with 100 μlo f
20% formalin resulted in a strong noxious reaction. Rat numbers: Fp = 9, Fm5 = 7, Fm10 = 6, Fm20 = 7. ** p < 0.01 vs. Fp;
+ p < 0.05,
++ p <
0.01 vs. Fm5; one-way ANOVA with Bonferroni’s post hoc test.
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Page 4 of 13electrical stimulation. When the electrical intensity
exceeded 50×TI, a profile of characteristic behaviors
including vigorous leg withdrawal, shaking off of the sti-
mulating needles, and/or turn of body in the tube were
observed. This finding was consistent with our previous
study that most conscious rats cannot tolerate electrical
intensities beyond 10×TI and exhibit similar behaviors
[24]. Though the rats in the current study were anesthe-
tized, it was believed that the E50 stimulation were still
noxious enough to induce neuronal reactions.
1.2. An adequate concentration of injected formalin to
induce pain
Formalin injected into the plantar surface induced
stronger pain than injection into the muscles. Biphasic
pain pattern, typically seen after i.pl. formalin, was also
observed after i.m. injection (Fig. 1), however, some dif-
ferences in behaviors were shown. Intramuscular forma-
lin induced much fewer flinch activities (pain score = 3)
but longer hind paw elevation (pain score = 1-2) com-
pared to those after i.pl. injections.
Dose-dependent hyperalgesic responses were shown in
the i.m. formalin groups from concentrations of 5% to
20%. In the Fm20 group, pain in the early phase was
not so evident, but pain score in the late phase was high
because of persistent hind paw elevation. Data analysis
showed that the Fm20 and the Fp groups had compar-
able maximal pain (1.90 ± 0.25 at 35 min in Fm20 vs.
1.91 ± 0.11 at 40 min in Fp, Fig. 1A) and comparable
cumulative scores in the late phase (14.56 ± 1.71 for the
Fm20 vs. 13.23 ± 1.12 for the Fp, p = 1.00) (Fig 1B). In
the early phase, the Fm20 group had a lower score than
the Fp group but the difference was insignificant
(p =0 . 5 0 ) .T h e r e f o r e ,a ni . m .i n j e c t i o no f1 0 0μlo f2 0 %
formalin was proved to be noxious and this dose was
chosen as a conditioning stimulus.
The spread of methylene blue was examined in four
rats. Dense deep-blue staining was confined to the deep
layer of the anterior tibial muscle and was scarcely dis-
persed through the interosseous membrane. No blue
staining was found in the posterior calf muscles.
2. Supramaximal electrical stimulation and i.m. formalin
both induced a significant increase in Fos expression in
the spinal dorsal horns
Whether the two conditioning stimuli produced differ-
ent neuronal responses were examined with a profile of
Fos-ir expression in the spinal dorsal horn. As shown in
Fig. 2, rats in the control and E20 groups (low-intense
stimulation) exhibited very few Fos-ir profiles from the
L2 to L5 dorsal horns (Fig. 2A, B, G, H); however, the
E50 and Fm20 groups showed marked Fos expressions
in the superficial laminae (Fig. 2C, E), which were signif-
icantly higher than those of the control (p < 0.01) and
E20 groups (p < 0.05 or 0.01, Fig. 3) at L2-L5 segments
(Fig. 3). In comparison, Fos expression of the E50 group
was densely distributed in the medial half of the superfi-
cial laminae of the L2-L3 segments, whereas Fos in the
Fm20 group was loosely scattered in the superficial
laminae of the same segments. In the lower L4-5 seg-
ments, Fos-ir cells of both the E50 and Fm20 groups
were evenly expressed in superficial layers (Fig. 2D, F).
The activated patterns of postsynaptic neurons were
thus shown differently between the two conditioning
stimulations.
3. Both noxious stimulations produced DNIC
3.1. Electrical stimulation prolonged TFLs in an intensity-
dependent manner
Under constant anesthesia, the control group main-
tained stable TFLs for 90 min, and graded electrical sti-
mulation produced intensity-dependent suppression on
tail-flick withdrawals during and after the stimulation
period (Fig. 4A, B). E10 stimulation, using an EA-like
intensity, mildly prolonged the TFL from time 0 to 40,
and showed an after-effect during time 80 to 90. The
maximal MPE of the E10 at time 20 was significantly
higher than that of the control (p < 0.001). The supra-
maximal E50 stimulation produced strong analgesia for
over 90% withdrawal inhibition at time 20-30, followed
by a prolonged after-effect. Nevertheless, the E50 rat did
not show traumatic signs, such as licking, elevating,
limping, or local tissue inflammation at 1 wk of follow-
up.
3.2. Formalin injection produced a different pattern of tail
flick depression
Noxious formalin (20%, 100 μl) suppressed tail withdra-
wal with a pattern differed from that of E50 stimulation.
Immediate and short-lived analgesia occurred in the
first 10 min after the injection, followed by increasing
suppression of the tail-flick response (Fig. 4C).
Obviously, the DNIC effect was correlated with an
inflammatory process of the tibial muscle. This forma-
lin-induced ongoing pain diff e r e df r o mt h eE 5 0 - e v o k e d
short-term pain, because the latter depends on the exis-
tence of electrical stimulation. Even though the current
data revealed that both stimuli may have distinct DNIC
patterns, there were no differences in the cumulative
pain scores (Fig. 4D).
4. DNIC induced by supramaximal electrical and noxious
formalin stimulation were mediated by different
inhibitory pathways
Interestingly, the naloxone injection did not significantly
reverse E50-induced DNIC in tail-flick responses. No sta-
tistical difference was found between the E50 and E50
+Nal groups, regardless of the time-to-time comparison
or cumulative analgesic calculation (E50 vs. E50+Nal,
p > 0.05) (Fig. 5A, B). Meanwhile, it was shown that
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Page 5 of 13Figure 2 Rostrocaudal distribution of Fos-immunoreactive (Fos-ir) neurons after two conditioning noxious stimulations. Fos-ir neurons
were identified at the L2 (A, C, E, G) and L5 (B, D, F, H) spinal dorsal horn at 90 min after the E20 and Fm20 stimulations. The groups shown in
the figure are: the E20 (A, B), E50 (C, D), Fm20 (E, F), and control groups (G, H). Fos-ir neurons were few in the control and E20 rats at all
segments (A, B, G, H). Formalin (Fm20) and supramaximal electrical (E50) stimulation induced Fos expression in L2 and L5 superficial laminae
(C-F). In comparison, E50-induced Fos-ir neurons were densely distributed at the medial one-third of the L2 superficial dorsal horn (C), whereas
Fm20-induced expression was relatively loosely distributed in the superficial dorsal horns (E). Scale bar = 100 μm.
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Page 6 of 13naloxone per se did not affect basal TFLs in the control.
On the other hand, naloxone evidently reversed Fm20-
induced DNIC, and antagonism was shown in the early
(time 10) and late (time points 60, 70, and 90) periods
(all p < 0.05, Fig. 5C). The Fm20+Nal group had a signifi-
cantly lower area under the curve (AUC) than the Fm20
group by 57% (p < 0.05) (Fig. 5D). The results showed
that noxious formalin, but not E50 stimulation, produced
an opioid-dependent DNIC.
In contrast, the selective a2 receptor antagonist,
yohimbine, showed a different action. Intrathecal yohim-
bine did not affect the basal TFLs in the control; how-
ever, DNIC of both conditioning nociception were
significantly attenuated by i.t. administration of 30 μg
yohimbine (Fig. 6). In both the E50 and Fm20 groups,
yohimbine reversed DNIC for long-lasting periods
(Fig. 6A, C). The analgesic summation (AUC) demon-
strated a strong DNIC reversion of over 60% in
both groups (In E50, from 45.35 ± 6.27 to 17.99 ± 7.28,
p < 0.05; in Fm20, from 47.06 ± 4.15 to 10.99 ± 4.06,
p < 0.001). The results proved that the a2-adrenergic
pathway is involved in DNIC produced by either nox-
ious electrical or formalin stimulation.
Discussion
Our study on DNIC from two different types of condi-
tioning stimuli, the supramaximal electrical stimulation
and high-concentration formalin injection, reveals sev-
eral findings. First, under a minimal-stress anesthetic
condition, the supramaximal electrical stimulation,
usually > 20 mA, induced much-stronger suppression of
the tail withdrawal reflex than a low-intensity EA-like
stimulation; second, formalin injection-induced muscu-
lar pain also elicited DNIC; third, noxious electrical and
formalin stimulation induced Fos expression with a dis-
tinct topographical distribution in the spinal dorsal
horns; and fourth, most importantly, the two condition-
ing stimuli triggered distinct underlying inhibitory
pathways.
The DNIC behaviors differed between the two
conditioning stimuli
DNIC has been suggested to be dependent on the con-
ditioning stimuli of different qualities, noxious intensi-
ties, durations, and locations [9,28-31]. We found an
intensity-dependent inhibition of the tail flick reflex by
graded conditioning electrical stimulations in this and a
Figure 3 Numerical analysis of Fos-ir neurons at the side ipsilateral to the conditioning stimulus. Fos-labeled neurons were significantly
higher in the Fm20 and E50 groups than in the control and E20 groups regardless of the spinal segment. No significant difference was found
between the C and E20 groups, or between the Fm20 and E50 groups for all segments and laminae. Topographically, E50-induced Fos
expression was higher in the higher segments (L2 and L3) than in the lower lumbar segments (L4 and L5). S, superficial laminae I/II; NP, nucleus
proprius, laminae III/IV; D, deep laminae V; DH, dorsal horn. Rat numbers: C = 6, E20 = 6, E50 = 5, Fm20 = 6. * p < 0.05, ** p < 0.01 vs. C;
+ p <
0.05,
++ p < 0.01 vs. E20; one-way ANOVA with Bonferroni’s post hoc test.
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ent DNIC responses to various conditioning stimuli.
The maximal DNIC effect in the E50 group appeared at
the end of the electrical stimulus, whereas in the forma-
lin group, the effect exhibited two peaks, one at the
beginning and the other at the end of observation. The
results apparently reflect a correlation between DNIC
and noxious levels of the conditioning stimuli.
The activated peripheral nociceptors and projecting
neurons by electricity and formalin may differ, which
can partially explain the variations in DNIC. It is possi-
ble that E50 excites certain groups of mechano-recep-
tors concentric to the electrical field, while injected
formalin might diffuse to a broader region in the mus-
cles and sensitize different groups of mechano- and
chemo-receptors. In the meanwhile, the variation in the
spinal Fos distribution provides additional evidence that
post-synaptic neurons were differentially activated by
both stimuli. Although Fos-expressing mapping is insuf-
ficient to justify the nociceptive quality, our immunos-
taining data are still informative at disclosing variations
in the activation of CNS pathways.
Supramaximal electrical stimulation-induced DNIC is
naloxone irreversible, but yohimbine reversible
The supramaximal electrical stimulation in this study is
an extrapolated example of EA, an intentional design
which can be compared to our previous study [24]. The
endogenous opioid system is a pivotal mechanism in EA
analgesia [32-34] and also contributes to DNIC [35,36].
Figure 4 Effect of noxious electrical and formalin stimulation-induced DNIC on the tail-flick latency. (A, B) Halothane-anaesthetized rats
were grouped into sham needles (C), E10 (10× twitch intensity), E20, and E50 (> 50×) electrical stimulation of the right ST36 acupoint. Changes
in tail-flick latencies were compared by the “maximal possible effect”. Control rats exhibited consistent tail-flick latencies without anesthetic
influence. The electrical stimuli produced intensity-dependent analgesia on the tail reflex and showed maximal DNIC effects within the
stimulation period. Notably, E50 elicited a strong and long analgesic effect (B). (C, D) A high-dose formalin injection (Fm20) caused a distinct
DNIC pattern from E50 stimulation in tail-flick suppression. However, total pain summation (area under the curve) indicated no statistical
difference between E50 and Fm20 (D). The horizontal thick bar indicates the electrical stimulating period. Rat numbers: C = 11, E10 = 10,
E20 = 11, E50 = 9, Fm20 = 10. * p < 0.05, *** p < 0.001 vs. C;
++ p < 0.01,
+++ p < 0.001 vs. E10;
# p < 0.05,
### p < 0.001 vs. E20; one-way
ANOVA with Bonferroni’s post hoc test.
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quite controversial [16,31,37,38]. Moreover, it was sug-
gested that different mechanisms could be triggered to
suppress evoked potentials and tooth pain when the
intensities increased from just activating large afferent A
fibers to sufficiently recruiting C fibers [9,29].
In contrast to the concept that naloxone inhibited EA
analgesia [24,39,40], we did not find a naloxone-reversi-
ble DNIC in the supramaximal E50 group. Since the
supramaximal electrical stimulus activated broader
neural circuits (all types of sensory afferents) and brain
areas than did the lower-intense stimulations like EA
(which only activated Ab and Aδ fibers), it is presumed
that as the electrical intensity increases from low
(maybe no pain or only minimal pain) to high (strong
pain), there is a shift in the triggered mechanisms in the
central nervous system. Despite there were arguments
whether endogenous opioids participating in acupunc-
ture in rats [41-44], rabbits [45], and humans [46,47],
our data in the first instance suggest that it is better to
have a clear demarcation of the electrical intensity by
which the underlying mechanisms of DNIC analgesia
and acupuncture analgesia may differ.
On the other hand, yohimbine could reverse, though
partially, E50-induced DNIC analgesia. In another study,
when rats received 10× EA, the analgesia on an ankle
sprain was reversed by yohimbine and phentolamine, a
non-selective a antagonist, but not by terazosin, an a1
adrenergic antagonist [48]. Therefore, it was shown that
descending analgesia of electrical stimulation is com-
prised, at least partly, of a2-adrenoceptor-mediated inhi-
bition regardless of the stimulating intensity at a
noxious or innocuous level. Taken together, electricity-
triggered analgesia is classified into at least two
Figure 5 Contribution of the opioidergic pathway to DNIC. The opioid receptor was antagonized by a 2 mg/kg intraperitoneal naloxone
injection at time point 15 and 1 mg/kg at time point 30. Naloxone itself did not alter the tail-flick latency in the control group (A, the C+Nal
line). (A, B) The E50-induced DNIC was not reversed by naloxone administration, whereas the Fm20-induced DNIC was reversed in both the early
and late phases by time point-to-point comparisons (C) or by total pain summation (D). Veh, saline; Nal, naloxone. The horizontal thick bar
indicates the electrical stimulating period. Rat numbers: E50+Veh = 9, E50+NAL = 7, C+NAL = 9, Fm20+Veh = 10, Fm20+Nal = 9. ** p < 0.01,
*** p < 0.001 vs. C+Nal;
# p < 0.05 vs. Fm20+Nal; one-way ANOVA with Bonferroni’s post hoc test.
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ing at low intensities and a a2 adrenergic system cover-
ing a much-wider range of intensities (Fig. 7).
Noxious formalin-induced DNIC is both naloxone and
yohimbine reversible
We found that high-dose formalin induces local pain
and triggers DNIC which is reversed by naloxone. The
formalin injection caused local inflammation and tissue
injuries including muscles, fascia, vessels, and/or nerves.
In addition to direct sensitization of the central endo-
genous opioid system, the inflammation activated release
of proinflammatory cytokines and chemokines, and
enhanced the production of leukocyte-derived opioid
peptides [49,50]. For instance, Freund’sa d j u v a n t -
induced inflammation showed an peripheral action of
leukocyte-derived b-endorphin, met-enkephalin, and
dynorphin on the μ, δ, and  receptors, respectively, and
opioid-mediated antinociception [51]. Therefore, the
naloxone-reversible component in formalin-induced
DNIC could include both central and peripheral opioid
actions because intraperitoneal injection of naloxone
could be systemically absorbed. By no means, it is
demonstrated that formalin-induced DNIC consists of
opioid and non-opioid mechanisms, and the latter may
be inflammation-independent as in noxious electricity-
induced DNIC and a2-recptor mediated (Fig. 7).
Descending inhibitory modulation mediated through
spinal a2 receptor activation has been largely reported.
Electrical stimulating peripheral Aδ and C fibers [52,53]
or central noradrenergic cells [54] were found to trigger
the descending adrenergic system and release norepi-
nephrine in the spinal cord. Accumulating studies
demonstrated that spinal norepinephrine administration
[55-58] induced powerful antinociception or inhibited
the amplitude of monosynaptically evoked A delta-fiber
Figure 6 Contribution of the a2-adrenergic pathway to DNIC.T h ea2-adrenergic receptor was antagonized by an intrathecal yohimbine
injection of 30 μgi n2 0μl of saline, 15 min before the conditioning stimulus. Yohimbine did not alter the tail-flick latency in the control group
(A, C+Yoh line). Unlike naloxone, yohimbine had the ability to reverse the DNIC effect produced by both E50 (A, B) and Fm20 (C, D). Veh, saline;
Yoh, yohimbine. Rat numbers: E50+Veh = 9, E50+Yoh = 10, C+Yoh = 10, Fm20+Veh = 9, Fm20+Yoh = 9. * p < 0.05, ** p < 0.01, *** p < 0.001
vs. C+Yoh;
# p < 0.05,
## p < 0.01 vs. E50+Yoh (A, B) or vs. Fm20+Veh (C, D), respectively; one-way ANOVA with Bonferroni’s post hoc test.
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cell patch clamp technique [59]. However, spinal and
pontine a2-adrenoceptors have opposite effects on pain-
related behavior in neuropathic animals [60]. The cur-
rent study provides additional evidence that a formalin
injection stimulates yohimbine-reversible heterotopic
analgesia. Conclusively, it is suggested that activation of
the descending a2-adrenergic pathway may be a univer-
sal mechanism in DNIC effect through a variety of con-
ditioning stimuli [56,61,62].
Formalin-induced noxious inhibition or facilitation
Central nociceptive activation following peripheral inflam-
mation should be meticulously interpreted based on var-
ious conditions. Contradictory results may be obtained
because the opposing forces of descending modulations
(facilitation vs. inhibition) can be simultaneously activated
[3,63]. This study revealed that high-dose formalin
induced DNIC analgesia. However, nociceptive hypersen-
sitivity with a receptive field expansion is another probable
consequence of prolonged inflammation due to long-term
potentiation [64]. In rodents with acute monoarthritis (<
48 h), inhibition of trigeminal convergent neurons was
produced by mechanical or thermal stimulation of the
arthritic joint, whereas chronic arthritis of over 3 wk did
not show a DNIC effect [21]. A human study revealed no
difference in DNIC responses among patients with rheu-
matoid arthritis of over 5 years, < 1 year, and healthy con-
trols. However, those 5-yr arthritic patients showed more
pressure allodynia on the non-painful thighs than did 1-yr
patients, indicating higher sensitization, but not inhibition,
of somatosensory functions [22]. In these studies, pain
duration played a critical role in determining the balance
skewed to either side of two opposing forces. Unfortu-
nately, many other factors, such as noxious qualities (e.g.,
inflammatory vs. neuropathic), can bias this tug-of-war.
Therefore, more studies are necessary before introducing
DNIC in clinical treatment.
Clinical implications
The current DNIC study throws some light on EA
application. For a long time, the acupuncture “dose” was
efficacy relevant but remains a vague idea. Because acu-
puncture stimulating strength is largely empirical and
the analgesic effect is also affected by psychological
stressors such as nervousness, anxiety, and fear
[34,65-68], it is difficult to predict the effectiveness of
acupuncture in awake humans.
We found that stronger EA stimulation was more
effective. Since EA analgesia is weak, equivalent to a
morphine dose of 0.5 [69] to 2 mg/kg [24], increasing
the electrical intensity can possibly produce a higher
Figure 7 A scheme of the proposed DNIC circuitry activated by noxious electrical or formalin stimulations. Both noxious stimuli at the
hindlimb can excite projection neurons in the corresponding spinal dorsal horn (DH) to activate descending inhibitory systems (e.g.
noradrenergic pathway, NA) in the supraspinal structures to inhibit the noxious excitability in different spinal segments, e.g. the tail. In
comparison, noxious formalin and electroacupuncture (EA), which is a low-intense electrical stimulation and may not be DNIC-mediated,
produces analgesia through NA- and opioid-dependent actions (left upper panel), whereas the analgesic effect of noxious electrical stimulus may
not depend on activation of opioid receptors (opioid-independent, right upper panel). Symbols +: excitation; -: inhibition.
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Page 11 of 13effect. For this reason, patients under general anesthesia
are a suitable group of subjects to apply strong EA sti-
mulation. This assumption agrees with our clinical study
that preoperative high-frequency EA, which accumulated
greater energy output, resulted in less morphine con-
sumption than did the lower-frequency EA in the post-
operative period [70]. Certainly, the highest limit of
electrical power without causing tissue damage should
be determined beforehand.
Conclusions
DNIC is a well-known physiological phenomenon; how-
ever, its clinical value and application are unclear. This
animal study provides information of differential conse-
quences and mechanisms produced by two qualities of
conditioning stimuli, supramaximal electrical stimulation
and a noxious formalin injection. Clinical implications of
the two noxious stimuli are respectively discussed on
the basis of inflammatory states and perioperative
analgesia. We suggest that greater understanding of
DNIC analgesia, by structuring the complex descending
circuitry with specific mechanisms under different con-
ditioning, will help turn this theory into a useful clinical
pain control application.
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